A prospective clinical trial on prevention of catheter contamination using the hub protection cap for needleless injection device

American Journal of Infection Control

Volumn 39, Issue 4, 2011, Pages 309-313

  Oto, Jun ^a   Imanaka, Hideaki ^a   Konno, Masatoshi ^b   Nakataki, Emiko ^a   Nishimura, Masaji ^a  

^a TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

catheter related bloodstream infection; CR BSI; hub protection cap; intraluminal catheter contamination; Needleless injection device

Indexed keywords

ACHROMOBACTER XYLOSOXIDANS; ACINETOBACTER; ADULT; AGED; ARTICLE; BACILLUS; BACTERIUM CONTAMINATION; BACTERIUM ISOLATION; CATHETER INFECTION; CLINICAL EFFECTIVENESS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPARATIVE STUDY; CONTROLLED STUDY; CORYNEBACTERIUM; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; FEMALE; FILTER; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFUSION SYSTEM; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MICROCOCCUS; NEEDLESS INJECTION DEVICE; PROSPECTIVE STUDY; PROTECTIVE EQUIPMENT; RANDOMIZED CONTROLLED TRIAL; SPHINGOMONAS PAUCIMOBILIS; STAPHYLOCOCCUS EPIDERMIDIS; STENOTROPHOMONAS MALTOPHILIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BACTERIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION; CATHETERS; CROSS INFECTION; EQUIPMENT AND SUPPLIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79955625485     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2010.06.016     Document Type: Article

References (18)

1. Laupland KB, Kirkpatrick AW, Church DL, Ross T, Gregson DB. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population. J Hosp Infect 2004;58:137-45. (Pubitemid 39317884)
2. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 2002;51:1-29.
3. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs and attributable mortality. JAMA 1994;271:1598-601.
4. Sitges-Serra A, Hernandez R, Maestro S, Pi-Suner T, Garces JM, Segura M. Prevention of catheter sepsis: the hub. Nutrition 1997;13(Suppl):S30-5.
5. Linares J, Serra AS, Garau J, Perez JL, Martin R. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative culture of catheter hub and segment. J Clin Microbiol 1985;21:357-60. (Pubitemid 15168645)
6. Russo PL, Harrington GA, Spelman DW. Needleless intravenous systems: a review. Am J Infect Control 1999;27:431-4. (Pubitemid 29480635)
7. Brown JD, Moss HA, Elliott TSJ. The potential for catheter microbial contamination from a needleless connector. J Hosp Infect 1997;36:181-9. (Pubitemid 27354772)
8. Danzig LE, Short LJ, Collins K, et al. Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy. JAMA 1995;273:1862-4.
9. Cookson ST, Ihrig M, O'Mara EM, et al. Increased blood-stream infection rates in surgical patients associated with variation from recommended use and care following implementation of a needleless device. Infect Control Hosp Epidemiol 1998;19:23-7. (Pubitemid 128472658)
10. Casey AL,Worthington T, Lambert PA, Quinn D, Faroqui MH, Elliott TS. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector. J Hosp Infect 2003;54:288-93. (Pubitemid 37554924)
11. Bouza E, Munoz P, Lopez-Rodriguez J, et al. A needleless closed system device (CLAVE) protects from intravascular catheter tip and hub colonization: a prospective randomized study. J Hosp Infect 2003;54:279-87. (Pubitemid 37554923)
12. Yebenes JC, Vidaur L, Serra-Prat M, et al. Prevention of catheter-related bloodstream infection in critically ill patients using a disinfectable, needle-free connector: a randomized controlled trial. Am J Infect Control 2004;32:291-5. (Pubitemid 38993372)
13. Casey AL, Burnell S, Whinn H, Worthington T, Faroqui MH, Elliott TSJ. A prospective clinical trial to evaluate the microbial barrier of a needleless connector. J Hosp Infect 2007;65:212-8.
14. Seymour VM, Dhallu HA, Moss SE, Tebbs SE, Elliot TS. A prospective clinical study to investigate the microbial contamination of a needleless connector. J Hosp Infect 2000;45:165-8. (Pubitemid 30438981)
15. Lucet JC, Hayon J, Bruneel F, Dumoulin JL, Joly-Guillou ML. Microbiological evaluation of central venous catheter administration hubs. Infect Control Hosp Epidemiol 2000;21:40-2.
16. Oto J, Nishimura M, Morimatsu H, et al. Comparison of contamination between conventional 3-way stopcock and needleless injection device: a randomized controlled trial. Med Sci Monit 2007;13:CR417-21.
17. Menyhay SZ, Maki DG. Preventing central venous catheter-associated bloodstream infections: development of an antiseptic barrier cap for needleless connectors. Am J Infect Control 2008;36:S174.e1-5.
18. Warren DK, Zack JE, Mayfield JL, et al. The effect of an educational program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 2004;126:1612-8. (Pubitemid 39525038)